Last Price
0.02
Today's Change
+0.001 (5.26%)
Day's Change
0.019 - 0.02
Trading Volume
609,302
Market Cap
18 Million
Shares Outstanding
902 Million
Avg Volume
1,597,716
Avg Price (50 Days)
0.03
Avg Price (200 Days)
0.06
PE Ratio
-2.00
EPS
-0.01
Earnings Announcement
19-Feb-2025
Previous Close
0.02
Open
0.02
Day's Range
0.019 - 0.02
Year Range
0.016 - 0.125
Trading Volume
609,302
1 Day Change
5.26%
5 Day Change
17.65%
1 Month Change
-25.93%
3 Month Change
-60.00%
6 Month Change
-72.60%
Ytd Change
-78.49%
1 Year Change
-37.50%
3 Year Change
-63.64%
5 Year Change
-70.59%
10 Year Change
-78.60%
Max Change
-94.88%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.